The company's application included a submitted dose of 0.04 millimole gadolinium per kilogram of body weight. If approved, gadoquatrane would become the lowest dose macrocyclic gadolinium-based ...

More builders were also offering other types of discounts. The use of sales incentives was 62%, up from last month's 61%. These include mortgage-rate buydowns, where the builder offers a lower ...

"Canola is still a rocket ship," the analyst said. He added that if the rain does fall over the region on the weekend, "it would be a drink just at the right time." As well for canola, there were ...

As a result, restaurant spending generally will rise and set fresh records every year. The increase could reflect an ever-growing population, higher prices due to inflation or a long-term trend in ...

The United States Department of Justice Cell Phone Service Provider Agrees to Pay $500,000 for Imposing Unlawful Charges on Military Servicemembers ...

Given the number of threats on the horizon, investors who ascribe to the "nothing ever happens" philosophy risk becoming complacent, Cox said. Still, as history has shown, even when there is a bear ...

Diversified by geography and business mix, Fresenius should be able to benefit from ongoing growth in treating ESRD patients worldwide in the long run. Fresenius' balance sheet remains manageable, ...

The text - released by the Senate Finance Committee as part of the party's broader effort to pass new tax and spending legislation championed by President Donald Trump - shows that the legislation ...

U.S. stocks fell and oil prices rallied, after hopes for a quick resolution to the Israel-Iran conflict dimmed and President Trump left the G-7 summit without new trade deals. Industrial output fell ...

The building conflict between Israel and Iran had WTI crude oil futures up 2.8%. Russian gas accounted for about 19% of EU imports last year, down from roughly 45% before Moscow's invasion of Ukraine ...

Yum Brands named Chief Financial Officer Chris Turner as its next chief executive. Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion Deal would add a potential treatment for ...

The provider of life insurance, pensions, retirement and investment services is aiming to grow its core operating earnings per share by between 6% and 9% per year in the midterm. Find insight on UBS, ...